ELVN - Enliven Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$69.50
DETAILS
HIGH:
$80.00
LOW:
$59.00
MEDIAN:
$69.50
CONSENSUS:
$69.50
UPSIDE:
67.31%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0.3 | 0 | 0 | 0 | 0 | 0 | 0.0 | 0 | 0 |
| Gross Profit | (0.3) | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 | 0 |
| Operating Expenses | |||||||||
| R&D Expenses | 85.9 | 80.8 | 64.6 | 31.0 | 20.5 | 8.2 | 19.0 | 8.2 | 7.9 |
| SG&A Expenses | 33.8 | 23.8 | 19.0 | 7.8 | 4.3 | 1.1 | 5.1 | 2.4 | 1.0 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 119.4 | 104.6 | 83.5 | 38.8 | 24.8 | 9.3 | 24.1 | 10.7 | 8.9 |
| Operating Income | |||||||||
| Operating Income | (119.7) | (104.6) | (83.5) | (38.8) | (24.8) | (9.3) | (24.1) | (10.7) | (8.9) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 16.0 | 14.9 | 12.0 | 1.1 | 0.0 | 0.5 | 0.6 | 0 | 0 |
| Profitability | |||||||||
| EBITDA | (119.4) | (104.2) | (83.2) | (38.6) | (24.6) | (9.3) | (23.4) | (11.3) | 0.2 |
| EBIT | (119.7) | (104.6) | (83.5) | (38.8) | (24.8) | (9.3) | (23.5) | (11.3) | 0.2 |
| Income Before Tax | (103.7) | (88.8) | (71.6) | (37.7) | (24.7) | (19.0) | (23.5) | (11.3) | 0.2 |
| Income Tax Expense | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 |
| Net Income | (103.7) | (89.0) | (71.6) | (37.7) | (24.7) | (19.0) | (23.5) | (11.3) | 0 |
| Per Share Data | |||||||||
| EPS (Basic) | -1.83 | -1.89 | -2.01 | -6.03 | -3.17 | -4.31 | -5.43 | -2.62 | – |
| EPS (Diluted) | -1.83 | -1.89 | -2.01 | -6.03 | -3.17 | -4.31 | -5.43 | -2.62 | – |
| Shares Outstanding | 56.7 | 47.1 | 35.5 | 6.2 | 7.8 | 4.4 | 4.3 | 4.3 | 4.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 98.9 | 124.1 | 100.1 | 75.5 | 110.0 | 47.7 | 4.9 | 7.4 | 9.7 |
| Short-Term Investments | 363.7 | 189.3 | 153.0 | 0 | 0 | 40.5 | 24.0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 12.3 | 4.7 | 10.1 | 2.2 | 0 | 2.2 | 1.7 | 0.3 | 0.6 |
| Total Current Assets | 474.9 | 318.1 | 266.2 | 77.8 | 110.7 | 90.4 | 30.6 | 7.7 | 10.2 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 0.4 | 0.5 | 1.1 | 1.5 | 1.0 | 0.3 | 0.4 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.1 | 0 | 0 |
| Other Non-Current Assets | 0.9 | 7.2 | 4.7 | 4.0 | 1.7 | 0.1 | 2.1 | 0 | 0 |
| Total Non-Current Assets | 1.3 | 7.6 | 5.7 | 5.5 | 2.7 | 0.4 | 2.7 | 0 | 0 |
| Total Assets | 476.2 | 325.8 | 271.9 | 83.3 | 113.3 | 90.8 | 33.3 | 7.7 | 10.2 |
| Current Liabilities | |||||||||
| Account Payables | 2.2 | 1.3 | 0.5 | 3.4 | 2.5 | 2.0 | 1.7 | 0.9 | 0.4 |
| Short-Term Debt | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 5.5 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 14.0 | 0.2 | 10.4 | 0.3 | 0.2 | 3.2 | 1.7 | 0.8 | 0.2 |
| Total Current Liabilities | 16.6 | 15.9 | 25.9 | 9.7 | 5.8 | 6.2 | 4.2 | 1.8 | 0.8 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.7 |
| Deferred Tax Liabilities | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0.1 | 150.4 | 0.7 | 0.2 | 0.2 | 32.2 | 0 |
| Total Non-Current Liabilities | 0.1 | 0 | 0.1 | 150.4 | 0.7 | 0.2 | 0.2 | 32.2 | 0.7 |
| Total Liabilities | 16.7 | 15.9 | 26.0 | 160.1 | 6.5 | 6.4 | 4.4 | 1.8 | 1.5 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (347.2) | (243.5) | (154.4) | (82.9) | (45.2) | (96.1) | (54.8) | (31.3) | (20.0) |
| Accumulated Other Comprehensive Income | 0.3 | 0.1 | 0.1 | (0.1) | 0 | 0.0 | 0.0 | 0 | 0 |
| Total Stockholders' Equity | 459.6 | 309.8 | 245.9 | (76.8) | 106.9 | 84.4 | (48.8) | (26.3) | (15.5) |
| Total Liabilities & Equity | 476.2 | 325.8 | 271.9 | 83.3 | 113.3 | 90.8 | 33.3 | 7.7 | 10.2 |
| Debt Metrics | |||||||||
| Total Debt | 0.4 | 0 | 0.3 | 0.3 | 0.2 | 0 | 0 | 0 | 0.7 |
| Net Debt | (98.5) | (124.1) | (99.8) | (75.2) | (109.9) | (47.7) | (4.9) | (7.4) | (9.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Net Income | (103.7) | (89.0) | (71.6) | (37.7) | (24.7) | (19.0) | (23.5) | (11.3) | 0 |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | 0.0 | 0.0 | 0 | 0 |
| Stock-Based Compensation | 34.0 | 20.2 | 12.9 | 3.2 | 1.9 | 0.1 | 0.9 | 0.6 | 0 |
| Change in Working Capital | (1.1) | (4.5) | 1.4 | 0.4 | 3.6 | 0.6 | 0.7 | 1.2 | (0.2) |
| Other Non-Cash Items | 0.2 | (0.1) | (4.3) | 1.7 | 3.8 | 9.7 | 0.2 | 0.8 | (7.9) |
| Operating Cash Flow | (70.3) | (73.2) | (61.3) | (32.1) | (19.1) | (8.5) | (21.9) | (8.8) | (8.8) |
| Investing Activities | |||||||||
| Capital Expenditure | (0.2) | (0.0) | (0.1) | (0.6) | (0.2) | (0.5) | (0.1) | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (446.8) | (350.7) | (268.3) | (35) | (47.6) | (64.2) | (23.9) | 0 | 0 |
| Sales/Maturities of Investments | 272.9 | 313.9 | 120 | 41.9 | 45.9 | 47.5 | 0 | 0 | 0 |
| Other Investing Activities | 0.2 | 0.9 | 0 | (41.9) | 1.6 | 16.7 | 0 | 0 | 0 |
| Investing Cash Flow | (173.8) | (36.0) | (148.4) | (0.6) | (0.2) | (0.5) | (24.1) | 0 | 0 |
| Financing Activities | |||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | (2.0) | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 94.0 | 73.1 | (0.6) | 0 | 33.6 | 0 | 6.5 | 11 |
| Financing Cash Flow | 218.9 | 133.2 | 234.3 | (1.8) | (1.0) | 130.5 | 43.6 | 6.5 | 11 |
| Cash Position | |||||||||
| Net Change in Cash | (25.3) | 24.0 | 24.6 | (34.5) | (20.3) | 121.5 | (2.4) | (2.3) | 2.2 |
| Cash at Beginning | 124.2 | 100.2 | 75.6 | 110.1 | 130.4 | 8.9 | 7.4 | 9.7 | 7.5 |
| Cash at End | 98.9 | 124.2 | 100.2 | 75.6 | 110.1 | 130.4 | 4.9 | 7.4 | 9.7 |
| Free Cash Flow | (70.5) | (73.2) | (61.4) | (32.7) | (19.3) | (9.0) | (22.0) | (8.8) | (8.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | (0.3) | 0 | 0 | 0 | 0 | 0 | (0.0) | 0 | 0 |
| Operating Income | (119.7) | (104.6) | (83.5) | (38.8) | (24.8) | (9.3) | (24.1) | (10.7) | (8.9) |
| Net Income | (103.7) | (89.0) | (71.6) | (37.7) | (24.7) | (19.0) | (23.5) | (11.3) | 0 |
| EPS (Diluted) | -1.83 | -1.89 | -2.01 | -6.03 | -3.17 | -4.31 | -5.43 | -2.62 | – |
| Balance Sheet | |||||||||
| Cash & Equivalents | 98.9 | 124.1 | 100.1 | 75.5 | 110.0 | 47.7 | 4.9 | 7.4 | 9.7 |
| Total Assets | 476.2 | 325.8 | 271.9 | 83.3 | 113.3 | 90.8 | 33.3 | 7.7 | 10.2 |
| Total Debt | 0.4 | 0 | 0.3 | 0.3 | 0.2 | 0 | 0 | 0 | 0.7 |
| Stockholders' Equity | 459.6 | 309.8 | 245.9 | (76.8) | 106.9 | 84.4 | (48.8) | (26.3) | (15.5) |
| Cash Flow | |||||||||
| Operating Cash Flow | (70.3) | (73.2) | (61.3) | (32.1) | (19.1) | (8.5) | (21.9) | (8.8) | (8.8) |
| Capital Expenditure | (0.2) | (0.0) | (0.1) | (0.6) | (0.2) | (0.5) | (0.1) | 0 | 0 |
| Free Cash Flow | (70.5) | (73.2) | (61.4) | (32.7) | (19.3) | (9.0) | (22.0) | (8.8) | (8.8) |